Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Diabetologia|April 8, 2016
Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trialStephen E Gitelman, Peter A Gottlieb, Eric I Felner, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trialStephen E Gitelman, Peter A Gottlieb, Mark R Rigby, et al.
Diabetes Care|September 14, 2023
Hydroxychloroquine in Stage 1 Type 1 DiabetesIngrid Libman, Polly J Bingley, Dorothy Becker, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trialMark R Rigby, Linda A DiMeglio, Marc S Rendell, et al.
Diabetes Care|March 15, 2023
Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled TrialWilliam E Russell, Brian N Bundy, Mark S Anderson, et al.
The Journal of Clinical Investigation|July 21, 2015
Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patientsMark R Rigby, Kristina M Harris, Ashley Pinckney, et al.
Diabetes|January 21, 2026
Phase I Clinical Trial of Islet Antigen-Specific Plasmid Coexpressing Tolerogenic Proteins Demonstrates Safety in Adults With Type 1 DiabetesCarla J Greenbaum, S Alice Long, Stephen E Gitelman, et al.
JCI Insight|November 8, 2021
IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetesCarla J Greenbaum, Elisavet Serti, Katharina Lambert, et al.
Pageof 3